NRIX icon

Nurix Therapeutics
NRIX

Overview Fund Activity

130 hedge funds and large institutions have $508M invested in Nurix Therapeutics in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 23 closing their positions.

Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
45
Reduced
38
Closed
23
Calls
$575K
Puts
$61K
Net Calls
+$514K
Net Calls Change
+$498K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$64.7M
2
TCM
2
TCG Crossover Management
California
$7.41M
3
AIM
3
ARK Investment Management
Florida
$33M
4
Deutsche Bank
4
Deutsche Bank
Germany
$5.2M
5
AAA
5
Affinity Asset Advisors
New York
$7.12M

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
State Street
2
State Street
Massachusetts
$9.51M
3
WA
3
Wasatch Advisors
Utah
$28.4M
4
SCM
4
Soleus Capital Management
Connecticut
$1.48M
5
Bank of America
5
Bank of America
North Carolina
$195K
Name Holding Trade Value Shares
Change 		Shares
Change %
PMEF
151
Point72 Middle East FZE
United Arab Emirates
– -$5.12K -651 Closed
LC
152
Lindbrook Capital
California
– -$2.62K -333 Closed
3 4 5 6
7